Coherus Distances Itself From Biosimilar Interchangeability

US Humira Biosimilars May Feature Designation In 2023

 
• By Dean Rudge
  
Railway tracks with switches and interchanges at a main line in Germany with geometrical structures black and white
A lack of interchangeability has not hindered biosimilar uptake in Europe, Coherus argues • Source: Shutterstock

More from Biosimilars

More from Products